Evidence map›Paper›PMID 35422779›Full record

ArticleFrontiers in microbiology2022

Pathogenic

Reetika Chaurasia, Alan S Marroquin, Joseph M Vinetz, Michael A Matthias

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evolutionary insights into the emergence of virulentbioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Editorial: Leptospirosis: pathogenesis, clinical and epidemiological aspects.Frontiers in cellular and infection microbiology · 2023
    Article
  15. Comparison of the PF07598-Encoded Virulence-Modifying Proteins ofTropical medicine and infectious disease · 2022
    Review
  16. Article
  17. Vaccination WithFrontiers in cellular and infection microbiology · 2022
    Article
  18. Frontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reetika ChaurasiaSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Alan S MarroquinSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Joseph M VinetzSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Michael A MatthiasSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.

Funding

Predicting Risk of Human Leptospiros by Environmental SurveillanceR01AI108276 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2013 to 2017
$3.6M
Draft Scientific ComponentU19AI115658 · NIAID · YALE UNIVERSITY · PI AGAMPODI, SUNETH BUDDHIKA · 2015 to 2019
$1.9M
Culture Independent Leptospira Comparative Whole Genome AnalysisR21AI164106 · NIAID · YALE UNIVERSITY · PI MATTHIAS, MICHAEL A · 2021 to 2022
$461k
B12 Autotrophy as a Virulence Mechanism in Infectious LeptospiraR21AI115273 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MATTHIAS, MICHAEL A · 2015 to 2016
$426k
NIAID NIH HHS R01 AI108276NIAID NIH HHS R21 AI115273NIAID NIH HHS R21 AI164106NIAID NIH HHS U19 AI115658
6 · The paper itself

Abstract

Leptospirosis is a globally important neglected zoonotic disease. Previous data suggest that a family of virulence-modifying (VM) proteins (PF07598) is a distinctive feature of group I pathogenic

Indexed as

comparative genomicscytopathic effectcytotoxinevolutiongenotoxinlectinpathogenesisvirulence factor

Identifiers

PMID35422779
PMCPMC9002632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.